A substantial advancement in diabetes treatment is emerging with the release of tirzepatide at a dosage of 45mg. This new version builds upon the existing success of tirzepatide, a dual GIP and GLP-1 agonist, and https://bookmarkshut.com/story22888763/groundbreaking-approach-tirzepatide-45mg-for-diabetes-management